Involvement of visinin-like protein-1 (VSNL-1) in regulating proliferative and invasive properties of neuroblastoma

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2122-2130

  Xie, Yi ^a   Chan, Hiuman ^a   Fan, Jianqing ^b   Chen, Yongxiong ^a   Young, Joseph ^a   Li, Wen ^a   Miao, Xiaoping ^a   Yuan, Zhengwei ^c   Wang, Huanmin ^d   Tam, Paul K H ^a   Ren, Yi ^a,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCETON UNIVERSITY   (United States)

^c CHINA MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CD44V6 ANTIGEN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; VISININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; UPREGULATION;

BRAIN NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CLONE CELLS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEUROBLASTOMA; NEUROCALCIN; SIGNAL TRANSDUCTION;

EID: 35148837124     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm147     Document Type: Article

References (54)

1. Jiang,Z. et al. (2006) Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: A retrospective study. Lancet Oncol., 7, 556-564.
2. Brodeur,G.M. (2003) Neuroblastoma: Biological insights into a clinical enigma. Nat. Rev. Cancer, 3, 203-216.
3. Pritchard,J. et al. (1994) Why does stage 4s neuroblastoma regress spontaneously? Lancet, 344, 869-870.
4. Cotterill,S.J. et al. (2000) Clinical prognostic factors in 1277 patients with neuroblastoma: Results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J. Cancer, 36, 901-908.
5. DuBois,S.G. et al.(1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J. Pediatr. Hematol. Oncol., 21, 181-189.
6. Cowie,F. et al. (1997) Lung involvement in neuroblastoma: incidence and characteristics. Med. Pediatr. Oncol., 28, 429-432.
7. Kawamata,H. et al. (2003) Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray. Cancer Sci., 94, 699-706.
8. Park,M.Y. et al. (1999) Apoptosis induced by inhibition of contact with extracellular matrix in mouse collecting duct cells. Nephron, 83, 341-351.
9. McClatchey,A.I. (1999) Modeling metastasis in the mouse. Oncogene, 18, 5334-5339.
10. Burchill,S.A. et al. (2001) Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J. Clin. Oncol., 19, 1795-1801.
11. Iwakawa,M. et al. (1994) A murine model for bone marrow metastasis established by an i.v. injection of C-1300 neuroblastoma in A/J mice. Clin. Exp. Metastasis, 12, 231-237.
12. Douma,S. et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature, 430, 1034-1039.
13. Ormerod,E.J. et al. (1989) Different growth responses to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity. Clin. Exp. Metastasis, 7, 85-95.
14. Gao,C.F. et al. (2005) Proliferation and invasion: Plasticity in tumor cells. Proc. Natl Acad. Sci. USA, 102, 10528-10533.
15. Toker,A. et al. (2006) Akt signaling and cancer: Surviving but not moving on. Cancer Res., 66, 3963-3966.
16. Ho,R. et al. (2002) Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res., 62, 6462-6466.
17. Handra-Luca,A. et al. (2003) Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: Association to aggressive tumor behavior and tumor cell proliferation. Am. J. Pathol., 163, 957-967.
18. Weiss,L. (2000) Metastasis of cancer: A conceptual history from antiquity to the 1990s. Cancer Metastasis Rev., 191-XI, 193-383.
19. Mahloogi,H. et al. (2003) Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res., 63, 4997-5004.
20. Plopper,G.E. et al. (2000) Antibody-induced acivation of beta1 integrin receptors stimulates cAMP-dependent migration of breast cells on laminin-5. Mol. Cell Biol. Res. Commun., 4, 129-135.
21. Whelan,M.C. et al. (2003) Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J. Biol. Chem., 278, 327-334.
22. Frisch,S.M. et al. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124, 619-626.
23. Edsjo,A. et al. (2003) Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment. Lab. Invest., 83, 813-823.
24. Bordow,S.B. et al. (1998) Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J. Clin. Oncol., 16, 3286-3294.
25. Matsumoto,K. et al. (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55, 1798-1806.
26. Garcia-Lora,A. et al. (2003) MHC class I antigens, immune surveillance, and tumor immune escape. J. Cell. Physiol., 195 346-355.
27. Koopman,L.A. et al. (2000) Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J. Exp. Med., 191, 961-976.
28. Cromme,F.V. et al. (1994) Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br. J. Cancer, 69, 1176-1181.
29. Andratschke,M. et al. (2003) MHC-class I antigen expression on micro-metastases in bone marrow of patients with head and neck squamous cell cancer. Anticancer Res., 23, 1467-1471.
30. Bernards,R. et al. (1986) N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell, 47, 667-674.
31. van de Stolpe,A. et al.(1996) Intercellular adhesion molecule-1. J. Mol. Med., 74, 13-33.
32. Fujihara,T. et al. (1999) Decrease in ICAM-1 expression on gastric cancer cells is correlated with lymph node metastasis. Gastric Cancer 2, 221-225.
33. Hosch,S.B. et al. (1997) Expression and prognostic significance of immunoregulatory molecules in esophageal cancer. Int. J. Cancer, 74, 582-587.
34. Maeda,K. et al. (2002) Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol. Rep., 9 511-514.
35. Budinsky,A.C. et al. (1997) Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro. Int. J. Cancer, 71, 1086-1090.
36. Ogawa,Y. et al. (1998) Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin. Cancer Res., 4, 31-36.
37. Favrot,M.C. et al. (1991) Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens. Int. J. Cancer, 48, 502-510.
38. Gross,N. et al. (1992) Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. Int. J. Cancer, 52, 85-91.
39. Foreman,N.K. et al. (1993) Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication. Br J. Cancer, 67, 933-938.
40. Naganuma,H. et al. (1991) Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: Participation of ICAM-1 induction on target cells. Int. J. Cancer, 47, 527-532.
41. Webb,D.S. et al. (1991) Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J. Immunol., 146, 3682-3686.
42. Pandolfi,F. et al. (1992) Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer, 69, 1165-1173.
43. Goodison,S. et al. (1999) CD44 cell adhesion molecules. Mol. Pathol., 52, 189-196.
44. Koopman,G. et al. (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med., 177, 897-904.
45. Mayer,B. et al. (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet, 342, 1019-1022.
46. Wielenga,V.J. et al. (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53, 4754-4756.
47. Li,H. et al. (1993) Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res., 53, 5345-5349.
48. Gross,N. et al. (1994) CD44H expression by human neuroblastoma cells: Relation to MYCN amplification and lineage differentiation. Cancer Res., 54, 4238-4242.
49. Gao,A.C. et al. (1997) CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res., 57, 846-849.
50. Ross,J.S. et al. (1996) Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod. Pathol. 9, 854-860.
51. Gross,N. et al. (1997) Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells. Cancer Res., 57, 1387-1393.
52. Wielenga,V.J et al. (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53, 4754-4756.
53. Yamamichi,K. et al. (1998) Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Int. J. Cancer, 79, 256-262.
54. Ekici,S. et al. (2002) Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: Prognostic value of CD44v6 score. J. Urol., 167, 2037-2041.